Sheng‐Xiang Lin

6.6k total citations
163 papers, 5.4k citations indexed

About

Sheng‐Xiang Lin is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sheng‐Xiang Lin has authored 163 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 68 papers in Genetics and 66 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sheng‐Xiang Lin's work include Estrogen and related hormone effects (66 papers), Hormonal Regulation and Hypertension (56 papers) and Enzyme Structure and Function (37 papers). Sheng‐Xiang Lin is often cited by papers focused on Estrogen and related hormone effects (66 papers), Hormonal Regulation and Hypertension (56 papers) and Enzyme Structure and Function (37 papers). Sheng‐Xiang Lin collaborates with scholars based in Canada, China and United States. Sheng‐Xiang Lin's co-authors include Fernand Labrie, Van Luu‐The, Claude Labrie, Jacques Simard, Alain Bélanger, Donald Poirier, Arezki Azzi, Rong Shi, Zi-Gui Huang and Tsung‐Tsong Wu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Sheng‐Xiang Lin

163 papers receiving 5.3k citations

Peers

Sheng‐Xiang Lin
Koichi Ito Japan
Brian M. Martin United States
Leping Li United States
Hiroshi Ozaki Japan
Richard A. F. Dixon United States
Hitoshi Ikeda Japan
James Inglese United States
Harry Schachter Canada
Alberto Santos Denmark
Philip Andrews United States
Koichi Ito Japan
Sheng‐Xiang Lin
Citations per year, relative to Sheng‐Xiang Lin Sheng‐Xiang Lin (= 1×) peers Koichi Ito

Countries citing papers authored by Sheng‐Xiang Lin

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Xiang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Xiang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Xiang Lin more than expected).

Fields of papers citing papers by Sheng‐Xiang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Xiang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Xiang Lin. The network helps show where Sheng‐Xiang Lin may publish in the future.

Co-authorship network of co-authors of Sheng‐Xiang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Xiang Lin. A scholar is included among the top collaborators of Sheng‐Xiang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Xiang Lin. Sheng‐Xiang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Kexin, et al.. (2024). Dual amplification dynamic DNA network system for CRISPR/Cas12a based p53 gene detection. Analytica Chimica Acta. 1321. 343048–343048. 2 indexed citations
2.
Maltais, René, et al.. (2024). Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 242. 106544–106544. 1 indexed citations
3.
Li, Tang, et al.. (2023). New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1. The Journal of Steroid Biochemistry and Molecular Biology. 228. 106246–106246. 4 indexed citations
4.
5.
Zhang, Wenfa & Sheng‐Xiang Lin. (2023). Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2. Viruses. 15(2). 580–580. 7 indexed citations
6.
Wang, Ruixuan, et al.. (2022). CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer. Cancers. 14(4). 989–989. 8 indexed citations
7.
Wang, Ruixuan, et al.. (2021). Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic. Biomedicine & Pharmacotherapy. 137. 111232–111232. 6 indexed citations
8.
Zhang, Wenfa, et al.. (2020). Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks. The Journal of Physical Chemistry Letters. 11(11). 4430–4435. 56 indexed citations
9.
Ran, Qian, Yang Xiang, Chun Wu, et al.. (2019). CRIF1–CDK2 Interface Inhibitors: An Unprecedented Strategy for Modulation of Cell Radiosensitivity. Journal of the American Chemical Society. 141(4). 1420–1424. 11 indexed citations
10.
11.
Li, Tang, René Maltais, Donald Poirier, & Sheng‐Xiang Lin. (2018). Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide. The Journal of Physical Chemistry Letters. 9(18). 5275–5280. 19 indexed citations
12.
Baz, Mariana, et al.. (2016). Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors. Journal of the American Chemical Society. 138(50). 16212–16215. 45 indexed citations
13.
Lin, Sheng‐Xiang, Rong Shi, Xiaojian Hu, & T.M. Penning. (2016). Current physico-biochemistry in steroid research and status of structural biology for steroid-converting enzymes. The Journal of Steroid Biochemistry and Molecular Biology. 161. 1–4. 2 indexed citations
14.
Lin, Sheng‐Xiang, et al.. (2012). Correction: Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7. PLoS ONE. 7(4). 39 indexed citations
15.
Lin, Sheng‐Xiang, Jiong Chen, Mausumi Mazumdar, et al.. (2010). Molecular therapy of breast cancer: progress and future directions. Nature Reviews Endocrinology. 6(9). 485–493. 98 indexed citations
16.
Bao, Rui, Cong‐Zhao Zhou, Chunhui Jiang, et al.. (2009). The Ternary Structure of the Double-headed Arrowhead Protease Inhibitor API-A Complexed with Two Trypsins Reveals a Novel Reactive Site Conformation. Journal of Biological Chemistry. 284(39). 26676–26684. 49 indexed citations
17.
Qiu, Wei, Ming Zhou, Mausumi Mazumdar, et al.. (2006). Structure-based Inhibitor Design for an Enzyme That Binds Different Steroids. Journal of Biological Chemistry. 282(11). 8368–8379. 45 indexed citations
18.
Lin, Sheng‐Xiang, et al.. (2000). 3D-structure of human estrogenic 17β-HSD1: binding with various steroids. The Journal of Steroid Biochemistry and Molecular Biology. 73(3-4). 183–183. 9 indexed citations
19.
Han, Qing & Sheng‐Xiang Lin. (2000). The Study of Crystallization of Estrogenic 17β-Hydroxysteroid Dehydrogenase with DHEA and DHT at Elevated Temperature. Biochemical and Biophysical Research Communications. 277(1). 100–106. 6 indexed citations
20.
Azzi, Arezki, et al.. (1993). Preparation of the apoenzyme and holoenzyme forms of human 17β-hydroxysteroid dehydrogenase. Journal of Chromatography B Biomedical Sciences and Applications. 614(1). 159–163. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Ito Breakdown of academic impact, for papers by Brian M. Martin Breakdown of academic impact, for papers by Leping Li Breakdown of academic impact, for papers by Hiroshi Ozaki Breakdown of academic impact, for papers by Richard A. F. Dixon Breakdown of academic impact, for papers by Hitoshi Ikeda Breakdown of academic impact, for papers by James Inglese Breakdown of academic impact, for papers by Harry Schachter Breakdown of academic impact, for papers by Alberto Santos Breakdown of academic impact, for papers by Philip Andrews
Rankless by CCL
2026